A health product containing red yeast rice from Japan’s Kobayashi Pharmaceutical is suspected of causing the deaths of 5 people (photo online)
After a health product containing red yeast rice from Japan’s Kobayashi Pharmaceutical was suspected of causing the deaths of five people, the Ministry of Health, Labor and Welfare said it had received a report from Kobayashi Pharmaceutical that 786 consumers needed to see medical institution after taking red yeast rice health products 157 people developed kidney problems and required hospitalisation, and more than 1,500 inquiries were made to the government’s helpline.
The Japan Society of Nephrology has launched a questionnaire survey among member doctors and has so far confirmed that 47 people nationwide have developed kidney function problems after taking Kobayashi Pharmaceutical’s health products. The association noted in its interim report that 46 among the 47 people affected, had taken “Red Yeast Cholesterol Granules” and the other had taken “Visceral Fat Reduction + Cholesterol Lowering Granules”. drugs associated with consumption of other products Causes of endangering health. According to the report, 90% of users are between the ages of 40 and 69, and almost 70% are women. Their first treatment date was November last year, and around 80% of them were after January this year.
Between March 29 and April 1, Gifu County authorities conducted on-site investigations of four local factories that manufacture the healthcare products. The focus of the investigation is on the purchase location, vendors and sales volume. A specific report will be be introduced in the near future. Previously, Kobayashi Pharmaceutical’s factories in Osaka Prefecture and Wakayama Prefecture also received on-site investigations from local governments.
The original article was published on AM730
#Kobayashi #Pharmaceutical #Kidney #Injury #Controversy157 #people #hospitalized #health #product #harmed #health #consumers
